Ursodiol for the long-term treatment of primary biliary cirrhosis

New England Journal of Medicine

Volumn 330, Issue 19, 1994, Pages 1342-1347

  Poupon, Renee E ^a   Poupon, Raoul ^b   Balkau, Beverley ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOSPLENOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPOALBUMINEMIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0028294206     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199405123301903     Document Type: Article

References (39)

1. Markus BH, Dickson ER, Grambsch PM, Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989; 320: 1709-1713
2. Triger DR, Manifold IH, Cloke P, Underwood JCE D-penicillamine in primary biliary cirrhosis: two year results of a single centre, double-blind controlled trial. Gut 1980; 21: A919-A920 abstract.
3. Bassendine MF, Macklon AF, Mulcahy R, James OFW Controlled trial of high and low dose D-penicillamine (DP) in primary biliary cirrhosis (PBC): results at three years. Gut 1982; 23: A909-A909 abstract.
4. Epstein O, Jain S, Lee RG, D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet 1981; 1: 1275-1277
5. Matloff DS, Alpert E, Resnick RH, Kaplan MM A prospective trial of d-penicillamine in primary biliary cirrhosis. N Engl J Med 1982; 306: 319-326
6. Neuberger J, Christensen E, Portmann B, Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut 1985; 26: 114-119
7. Taal BG, Schalm SW, ten Kate FWJ, van Berge Henegouwen GP, Brandt K-H Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis. Liver 1983; 3: 345-352
8. Bodenheimer HC Jr, Schaffner F, Sternlieb I, Klion FM, Vernace S, Pezzullo J A prospective clinical trial of d-penicillamine in the treatment of primary biliary cirrhosis. Hepatology 1985; 5: 1139-1142
9. Dickson ER, Fleming TR, Wiesner RH, Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985; 312: 1011-1015
10. Heathcote J, Ross A, Sherlock S A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976; 70: 656-660
11. Crowe J, Christensen E, Smith M, Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980; 78: 1005-1010
12. Christensen E, Neuberger J, Crowe J, Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroenterology 1985; 89: 1084-1091
13. Hoofnagle JH, Davis GL, Schafer DF, Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986; 91: 1327-1334
14. Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OFW A controlled trial of prednisolone treatment in primary biliary cirrhosis: three-year results. J Hepatol 1992; 15: 336-344
15. Minuk GY, Bohme CE, Burgess E, Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 1988; 95: 1356-1363
16. Wiesner RH, Ludwig J, Lindor KD, A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990; 322: 1419-1424
17. Lombard M, Portmann B, Neuberger J, Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993; 104: 519-526
18. Kaplan MM, Alling DW, Zimmerman HJ, A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315: 1448-1454
19. Warnes TW, Smith A, Lee FI, Haboubi NY, Johnson PJ, Hunt L A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report. J Hepatol 1987; 5: 1-7
20. Bodenheimer H Jr, Schaffner F, Pezzullo J Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988; 95: 124-129
21. A European multicentre study groupThe results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. J Hepatol 1993; 17: 227-235
22. Poupon R, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; 1: 834-836
23. Poupon RE, Balkau B, Eschwege E, Poupon R, UDCA-PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-1554
24. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1-7
25. Ludwig J, Dickson ER, McDonald GSA Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch [Pathol Anat] 1978; 379: 103-112
26. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
27. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34: 187-220
28. Leuschner U, Fischer H, Kurtz W, Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989; 97: 1268-1274
29. Oka H, Toda G, Ikeda Y, A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterol Jpn 1990; 25: 774-780
30. Hadziyannis S, Hadziyannis E A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Hepatology 1988; 8: 1421-1421 abstract.
31. Battezzati PM, Podda M, Bianchi FB, Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: preliminary analysis of a double-blind multicenter trial. J Hepatol 1993; 17: 332-338
32. Combes B, Carithers RL Jr, McDonald MF, Ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology 1991; 14: Suppl: 91A-91A abstract.
33. Lindor KD, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Dickson ER Ursodeoxycholic acid (UDCA) is beneficial therapy for patients with primary biliary cirrhosis (PBC). Hepatology 1992; 16: Suppl: 91A-91A abstract.
34. Heathcote EJL, Cauch K, Walker V, The Canadian multi-centre double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1992; 16: Suppl: 91A-91A abstract.
35. Perdigoto R, Wiesner RH Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology 1992; 102: 1389-1391
36. Roll J, Boyer JL, Barry D, Klatskin G The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308: 1-7
37. Goudie BM, Burt AD, Macfarlane GJ, Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989; 84: 713-716 [Erratum, J Gastroenterol 1989;84:1474.]
38. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990; 25: 119-126
39. Babbs C, Smith A, Hunt LP, Rowan BP, Haboubi NY, Warnes TW Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Lancet 1988; 1: 1021-1024